A bill is quickly advancing in the Senate with bipartisan support to spend $120B on countering China's influence by boosting chip manufacturing, R&D, and more
The legislation has drawn bipartisan support amid the coronavirus pandemic as Democrats and Republicans have become increasingly concerned …
Context & Ripple Effects
This is the opening move of what the surrounding coverage shows became a long legislative slog: the Senate's bipartisan push to spend $120B on chips and R&D to counter China eventually stalled over unrelated disputes like climate provisions, leaving the funds delayed well past their original timeline.
The stakes were made concrete while Congress deliberated — by the time the debate stretched across 13 months, China's industry had produced an advanced 7nm chip rivaling Taiwanese production, and the House had passed its own competing America Competes Act at $350B versus the Senate's $250B version.
First-order effects
- Democrats and Republicans in the Senate gain a rare vehicle for bipartisan action on China policy, with chipmakers and research institutions positioned as the direct beneficiaries of manufacturing and R&D funding.
Second-order effects
- The bill must still survive merger with parallel efforts: a later Senate vote advanced ~$52B in chip production subsidies as the core of a larger package, meaning the final funding level and scope depend on reconciling House and Senate versions.
Third-order effects
- If the pattern holds, subsidy legislation becomes the template for US industrial policy toward semiconductors — but the coverage shows the clock matters more than the check: China's industry advanced during the 13-month deliberation, so legislative speed itself becomes a competitive variable.
The trend: US-China tech competition is institutionalizing through large bipartisan industrial-policy bills, with legislative delays emerging as their biggest execution risk.